Acquisition of Saber Interactive Inc. (US) by Embracer Group (SE) — USD 525 million TMT Acquisition of Saber Interactive Inc. (US) by Embracer Group (SE) — USD 525 million
Directed share issue in NCAB Group AB (SE) — SEK 287 million Industrials Directed share issue in NCAB Group AB (SE) — SEK 287 million
Directed new share issue in Nordic Aquafarms AS (NO) – NOK 88 million Business Services Directed new share issue in Nordic Aquafarms AS (NO) – NOK 88 million
Rights issue in Bambuser AB (SE) — SEK 101 million TMT Rights issue in Bambuser AB (SE) — SEK 101 million
Directed new share issue in Enad Global 7 AB (SE) – SEK 119 million TMT Directed new share issue in Enad Global 7 AB (SE) – SEK 119 million
Directed share issue in Faron Pharmaceuticals Oy (FI) – EUR 14.0 million Healthcare Directed share issue in Faron Pharmaceuticals Oy (FI) – EUR 14.0 million
Listing of Cellink AB (SE) on Nasdaq Stockholm Healthcare Listing of Cellink AB (SE) on Nasdaq Stockholm
Rights issue in IRRAS AB (SE) — SEK 217 million Healthcare Rights issue in IRRAS AB (SE) — SEK 217 million
Directed share issue in Embracer Group AB (SE) — SEK 1.6 billion TMT Directed share issue in Embracer Group AB (SE) — SEK 1.6 billion
Public cash offer to the shareholders in Sportamore AB (SE) by Footway Group AB (SE) – SEK 439 million Consumer & Retail Public cash offer to the shareholders in Sportamore AB (SE) by Footway Group AB (SE) – SEK 439 million
Divestment of Proliva AB (SE) by Praktikertjänst AB (SE) to Aleris Healthcare AB (SE) — Amount not disclosed Healthcare Divestment of Proliva AB (SE) by Praktikertjänst AB (SE) to Aleris Healthcare AB (SE) — Amount not disclosed
Carnegie acted as exclusive financial adviser to the Ageras group TMT Carnegie acted as exclusive financial adviser to the Ageras group